• <em>ApoA1</em> Deficiency Reshapes the Phenotypic and Molecular Characteristics of Bone Marrow Adipocytes in Mice
• A decreased level of high-density lipoprotein is a possible risk factor for type 2 diabetes mellitus: A review
• A novel homozygous frameshift mutation in the APOA1 gene associated with marked high-density lipoprotein deficiency
• A novel splicing variant in ABCA1 in the first reported Hong Kong Chinese patient with high-density lipoprotein deficiency
• ABC Transporters, Cholesterol Efflux, and Implications for Cardiovascular Diseases
• Administration of the High-Density Lipoprotein Mimetic CER-001 for Inherited Lecithin-Cholesterol Acyltransferase Deficiency
• AIBP protects retinal ganglion cells against neuroinflammation and mitochondrial dysfunction in glaucomatous neurodegeneration
• AIBP: A New Safeguard against Glaucomatous Neuroinflammation
• Aortic Gene Expression Profiles Show How ApoA-I Levels Modulate Inflammation, Lysosomal Activity, and Sphingolipid Metabolism in Murine Atherosclerosis
• ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice
• ApoA1 Deficiency Reshapes the Phenotypic and Molecular Characteristics of Bone Marrow Adipocytes in Mice
• Apolipoprotein A-1 Accelerated Liver Regeneration Through Regulating Autophagy Via AMPK-ULK1 Pathway
• Apolipoprotein A-1 protected hepatic ischaemia-reperfusion injury through suppressing macrophage pyroptosis via TLR4-NF-kappaB pathway
• Apolipoprotein A-1 protected hepatic ischaemia-reperfusion injury through suppressing macrophage pyroptosis via TLR4-NF-κB pathway
• Apolipoprotein A-I Reduces In-Stent Restenosis and Platelet Activation and Alters Neointimal Cellular Phenotype
• Apolipoprotein A1 deficiency in mice primes bone marrow stem cells for T cell lymphopoiesis
• Apolipoprotein A1 Protects Against Necrotic Core Development in Atherosclerotic Plaques: PDZK1-Dependent High-Density Lipoprotein Suppression of Necroptosis in Macrophages
• Apolipoprotein AI) Promotes Atherosclerosis Regression in Diabetic Mice by Suppressing Myelopoiesis and Plaque Inflammation
• Apolipoprotein-A-I for severe COVID-19-induced hyperinflammatory states: A prospective case study
• Apolipoprotein-mimetic nanodiscs reduce lipid accumulation and improve liver function in acid sphingomyelinase deficiency
• Assembly and Characterization of Biocompatible Coenzyme Q₁₀ -Enriched Lipid Nanoparticles
• Biofunctionalized graphene oxide nanosheet for amplifying antitumor therapy: Multimodal high drug encapsulation, prolonged hyperthermal window, and deep-site burst drug release
• CER-001 ameliorates lipid profile and kidney disease in a mouse model of familial LCAT deficiency
• Chylomicron retention disease: genetics, biochemistry, and clinical spectrum
• Correction of Familial LCAT Deficiency by AAV-hLCAT Prevents Renal Injury and Atherosclerosis in Hamsters-Brief Report
• Deletion of Lymphangiogenic and Angiogenic Growth Factor VEGF-D Leads to Severe Hyperlipidemia and Delayed Clearance of Chylomicron Remnants
• Determinants of high-density lipoprotein (HDL) functions beyond proteome in Asian Indians: exploring the fatty acid profile of HDL phospholipids
• Dietary Erythrodiol Modifies Hepatic Transcriptome in Mice in a Sex and Dose-Dependent Way
• Dietary Squalene Induces Cytochromes Cyp2b10 and Cyp2c55 Independently of Sex, Dose, and Diet in Several Mouse Models
• Dietary, macronutrient, micronutrient, and nutrigenetic factors impacting cardiovascular risk markers apolipoprotein B and apolipoprotein A1: a narrative review
• Distinct phospholipid and sphingolipid species are linked to altered HDL function in apolipoprotein A-I deficiency
• Efficacy and adverse reaction to different doses of atorvastatin in the treatment of type II diabetes mellitus
• Emerging roles for high-density lipoproteins in neurodegenerative disorders
• Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2<em>S</em>,4<em>R</em>)-4-¹⁸F-Fluoroglutamine
• Flipped C-Terminal Ends of APOA1 Promote ABCA1-Dependent Cholesterol Efflux by Small HDLs
• Folate and Vitamin B12 in Morbid Obesity: The Influence of Folate on Anti-Atherogenic Lipid Profile
• Genetic and secondary causes of severe HDL deficiency and cardiovascular disease
• Gut Microbiota-Associated Activation of TLR5 Induces Apolipoprotein A1 Production in the Liver
• HDL is the primary transporter for carotenoids from liver to retinal pigment epithelium in transgenic ApoA-I^-/-/Bco2^-/- mice
• Hepatic Forkhead Box Protein A3 Regulates ApoA-I (Apolipoprotein A-I) Expression, Cholesterol Efflux, and Atherogenesis
• Human apolipoprotein A-II reduces atherosclerosis in knock-in rabbits
• Hypoxia as a Factor Involved in the Regulation of the apoA-1, ABCA1, and Complement C3 Gene Expression in Human Macrophages
• Imbalance of APOB Lipoproteins and Large HDL in Type 1 Diabetes Drives Atherosclerosis
• Impact of apolipoprotein A1- or lecithin:cholesterol acyltransferase-deficiency on white adipose tissue metabolic activity and glucose homeostasis in mice
• Inborn errors of apolipoprotein A-I metabolism: implications for disease, research and development
• Inborn errors of high-density lipoprotein metabolism
• Insights into cardiovascular risk and nutritional status in subjects with wheat-related disorders
• Lack of ApoA-I in ApoEKO Mice Causes Skin Xanthomas, Worsening of Inflammation, and Increased Coronary Atherosclerosis in the Absence of Hyperlipidemia
• Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of Atherosclerosis
• LC-MS-Based Metabolomics and Lipidomics Study of High-Density-Lipoprotein-Modulated Glucose Metabolism with an apoA-I Knockout Mouse Model
• LCAT, ApoD, and ApoA1 Expression and Review of Cholesterol Deposition in the Cornea
• LDL Receptor Regulates the Reverse Transport of Macrophage-Derived Unesterified Cholesterol via Concerted Action of the HDL-LDL Axis: Insight From Mouse Models
• Lipoprotein modulation of proteinuric renal injury
• LncRNA APOA1-AS facilitates proliferation and migration and represses apoptosis of VSMCs through TAF15-mediated SMAD3 mRNA stabilization
• Long-term efficacy of olipudase alfa in adults with acid sphingomyelinase deficiency (ASMD): Further clearance of hepatic sphingomyelin is associated with additional improvements in pro- and anti-atherogenic lipid profiles after 42 months of treatment
• Low Density Lipoprotein promotes Microvascular Thrombosis by enhancing von Willebrand Factor Self-association
• Low-density lipoprotein promotes microvascular thrombosis by enhancing von Willebrand factor self-association
• Mechanistic Insights into the Activation of Lecithin-Cholesterol Acyltransferase in Therapeutic Nanodiscs Composed of Apolipoprotein A-I Mimetic Peptides and Phospholipids
• Methionine sulfoxide reductase A attenuates atherosclerosis via repairing dysfunctional HDL in scavenger receptor class B type I deficient mice
• Mitochondrial apolipoprotein A-I binding protein alleviates atherosclerosis by regulating mitophagy and macrophage polarization
• Myeloperoxidase Targets Apolipoprotein A-I for Site-Specific Tyrosine Chlorination in Atherosclerotic Lesions and Generates Dysfunctional High-Density Lipoprotein
• NAD⁺ Levels Are Augmented in Aortic Tissue of ApoE^-/- Mice by Dietary Omega-3 Fatty Acids
• Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice
• Ovarian cholesterol efflux: ATP-binding cassette transporters and follicular fluid HDL regulate cholesterol content in mouse oocytes†
• Oxidant resistant human apolipoprotein A-I functions similarly to the unmodified human isoform in delaying atherosclerosis progression and promoting atherosclerosis regression in hyperlipidemic mice
• Polydatin attenuates atherosclerosis in apolipoprotein E-deficient mice: Role of reverse cholesterol transport
• Positron Emission Tomography Imaging of Macrophages in Atherosclerosis with ¹⁸F-GE-180, a Radiotracer for Translocator Protein (TSPO)
• Promoting reverse cholesterol transport contributes to the amelioration of atherosclerosis by paeoniflorin
• Quantifying ABCA1/apoA-1 Signaling Pathways with AFM Imaging and Lipidomic Analysis
• Recombinant porphobilinogen deaminase targeted to the liver corrects enzymopenia in a mouse model of acute intermittent porphyria
• Regulation of ABCA1-mediated cholesterol efflux by sphingosine-1-phosphate signaling in macrophages
• Regulation of lipid rafts, angiogenesis and inflammation by AIBP
• Relation of High-Density Lipoprotein Charge Heterogeneity, Cholesterol Efflux Capacity, and the Expression of High-Density Lipoprotein-Related Genes in Mononuclear Cells to the HDL-Cholesterol Level
• Restoring AIBP deficiency in the retina provides neuroprotection in glaucoma
• Restoring AIBP expression in the retina provides neuroprotection in glaucoma
• rHDL modeling and the anchoring mechanism of LCAT activation
• Risk Factors of Vitamin D Deficiency in Chinese Ischemic Stroke Patients: A Cross-Sectional Study
• Role of enterocyte stearoyl-Co-A desaturase-1 in LDLR-null mice
• Role of vitamin D in risk factors of patients with type 2 diabetes mellitus
• Serum Amyloid A Is an Exchangeable Apolipoprotein
• Serum amyloid A is not incorporated into HDL during HDL biogenesis
• Serum apolipoprotein A-I depletion is causative to silica nanoparticles-induced cardiovascular damage
• Short-Term Acyl-CoA:Cholesterol Acyltransferase Inhibition, Combined with Apoprotein A1 Overexpression, Promotes Atherosclerosis Inflammation Resolution in Mice
• Site-specific 5-hydroxytryptophan incorporation into apolipoprotein A-I impairs cholesterol efflux activity and high-density lipoprotein biogenesis
• Specific Loss of ABCA1 (ATP-Binding Cassette Transporter A1) Suppresses TCR (T-Cell Receptor) Signaling and Provides Protection Against Atherosclerosis
• Sphingosine-1-Phosphate (S1P) Lyase Inhibition Aggravates Atherosclerosis and Induces Plaque Rupture in <em>ApoE^-/-</em>Mice
• Strikingly Different Atheroprotective Effects of Apolipoprotein A-I in Early- Versus Late-Stage Atherosclerosis
• Sulforaphane Inhibits Foam Cell Formation and Atherosclerosis via Mechanisms Involving the Modulation of Macrophage Cholesterol Transport and the Related Phenotype
• Synthetic lipoproteins based on apolipoprotein E coupled to fullerenol have anti-atherosclerotic properties
• Targeted profiling of amino acid metabolome in serum by a liquid chromatography-mass spectrometry method: application to identify potential markers for diet-induced hyperlipidemia
• The effect of the content of ApoA-I in peripheral blood on the state of immune homeostasis in people living in extreme climatic conditions of the Arctic
• The HDL from septic-ARDS patients with composition changes exacerbates pulmonary endothelial dysfunction and acute lung injury induced by cecal ligation and puncture (CLP) in mice
• The HDL mimetic CER-001 remodels plasma lipoproteins and reduces kidney lipid deposits in inherited lecithin:cholesterol acyltransferase deficiency
• The level of vitamin D using the LC-MS/MS method and related factors in healthy Korean postmenopausal women
• The Mechanism of Bisphenol A Atherogenicity Involves Apolipoprotein A-I Downregulation through NF-kappaB Activation
• The Mechanism of Bisphenol A Atherogenicity Involves Apolipoprotein A-I Downregulation through NF-κB Activation
• The Predictors of Early Treatment Effectiveness of Intravitreal Bevacizumab Application in Patients with Diabetic Macular Edema
• The Role of the ATP-Binding Cassette A1 (ABCA1) in Human Disease
• Treatment with apolipoprotein A1 protects mice against doxorubicin-induced cardiotoxicity in a scavenger receptor class B, type I-dependent manner
• Unravelling the influence of surface lipids on the structure, dynamics and interactome of high-density lipoproteins